Which has the lower trailing P/E, ABT or NVS?

NVS has the lower trailing P/E: ABT trades at 31.35 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or NVS?

Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus NVS at 1.53%.

Does ABT or NVS pay a bigger dividend?

ABT yields 2.54% and NVS yields 3.38% based on trailing dividends and the latest price.

Is ABT or NVS more profitable?

NVS runs the higher net margin — ABT at 11.65% versus NVS at 22.93%.

How have ABT and NVS total returns compared?

Over the past 10 years, ABT delivered 10.77% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Novartis AG (NVS)

A side-by-side comparison of Abbott Laboratories and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$168.71B

$97.50HealthcareDelayed quote: Oct 2, 2026, 4:02 PM EDT

NVS

Novartis AG

$268.00B

$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — ABT vs NVS

growth of $100 · dividends reinvested · last 10y

ABT +196.0% (+11.5%/yr)NVS +219.0% (+12.3%/yr)NVS compounded faster over this window

ABT NVS

ABT vs NVS: by the numbers

•NVS is the larger company ($268.00B vs $168.71B market cap).
•NVS trades at the lower trailing earnings multiple (21.27 vs 31.35 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 11.65% net margin).
•ABT grew revenue faster over the past five years (2.98% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 2.54%).

Metrics side by side

Valuation

Metric	ABT	NVS
P/E ratio	31.35	21.27
Forward P/E	17.67	16.02
PEG ratio	3.79	1.38
P/S ratio	3.62	4.82
P/B ratio	3.30	6.45
EV / EBITDA	18.02	13.85
FCF yield	N/A	5.90%

Profitability

Metric	ABT	NVS
Gross margin	56.80%	74.44%
Operating margin	17.03%	30.54%
Net margin	11.65%	22.93%
ROE	10.61%	30.71%
ROIC	6.07%	13.93%

Dividends

Metric	ABT	NVS
Dividend yield	2.54%	3.38%
Payout ratio	79.74%	71.50%

Growth (annualized)

Metric	ABT	NVS
Revenue CAGR (5Y)	2.98%	1.53%
EPS CAGR (5Y)	8.22%	15.42%
FCF CAGR (5Y)	N/A	8.92%
Total return CAGR (5Y)	-1.72%	16.96%

Frequently asked

Which has the lower trailing P/E, ABT or NVS?: NVS has the lower trailing P/E: ABT trades at 31.35 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or NVS?: Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus NVS at 1.53%.
Does ABT or NVS pay a bigger dividend?: ABT yields 2.54% and NVS yields 3.38% based on trailing dividends and the latest price.
Is ABT or NVS more profitable?: NVS runs the higher net margin — ABT at 11.65% versus NVS at 22.93%.
How have ABT and NVS total returns compared?: Over the past 10 years, ABT delivered 10.77% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Novartis AG P/E ratio Abbott Laboratories dividend yield Novartis AG dividend yield Abbott Laboratories ROE Novartis AG ROE Abbott Laboratories operating margin Novartis AG operating margin Abbott Laboratories revenue growth Novartis AG revenue growth Abbott Laboratories free cash flow Novartis AG free cash flow

Abbott Laboratories & Novartis AG appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.